ISTA Pharmaceuticals, Inc. announced the US Food and Drug Administration (FDA) has approved Bepreve (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
The details can be read here.
No comments:
Post a Comment